Genetic Technologies Ltd (GENE) Financials

GENE Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 5.8 million 2.5 million
2023-09-30 ? ?
2023-06-30 9.9 million 2.5 million
2023-03-31 10.0 million 2.5 million

GENE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -2.7 million ?
2023-09-30 -13498 ?
2023-06-30 -1.7 million 84074
2023-03-31 -691256 85049

GENE Net Income

No data available :(

GENE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 2.5 million - -
2023-09-30 - - -
2023-06-30 5.2 million - 353505
2023-03-31 5.3 million - -

GENE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 78.6 million
2023-09-30 ?
2023-06-30 61.3 million
2023-03-31 7.4 billion

GENE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 4769 265542 - -
2023-09-30 13498 - - -
2023-06-30 7961 479560 189086 430296
2023-03-31 671 242561 191279 435286

GENE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.7 million 4.0 million
2023-09-30 - -
2023-06-30 3.0 million 3.8 million
2023-03-31 1.8 million 734067

GENE

Price: $2.29

52 week price:
1.80
5.90

Earnings Per Share: -0.15 USD

P/E Ratio: -14.82

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 666231

Ebitda: -5.8 million

Market Capitalization: 10.7 million

Links: